| 0 |
CLAUDICATION OF JAW MUSCLES |
2 |
0.0333 |
| 1 |
PRODUCT CONTAMINATION CHEMICAL |
2 |
0.0092 |
| 2 |
BRONCHIAL NEOPLASM |
1 |
0.0074 |
| 3 |
EAR NEOPLASM |
2 |
0.0073 |
| 4 |
SUBGALEAL HAEMATOMA |
1 |
0.0060 |
| 5 |
BRONCHIAL HAEMORRHAGE |
1 |
0.0032 |
| 6 |
ENDOMETRIAL ABLATION |
1 |
0.0028 |
| 7 |
NASAL TURBINATE HYPERTROPHY |
1 |
0.0027 |
| 8 |
NEOPLASM SKIN |
2 |
0.0013 |
| 9 |
INTERMITTENT CLAUDICATION |
2 |
0.0013 |
| 10 |
HYPOREFLEXIA |
2 |
0.0010 |
| 11 |
RHONCHI |
1 |
0.0007 |
| 12 |
INFECTIOUS PLEURAL EFFUSION |
1 |
0.0007 |
| 13 |
BRONCHIAL DISORDER |
1 |
0.0006 |
| 14 |
ANTIBODY TEST POSITIVE |
1 |
0.0006 |
| 15 |
RECALLED PRODUCT |
1 |
0.0006 |
| 16 |
DRUG WITHDRAWAL CONVULSIONS |
1 |
0.0006 |
| 17 |
IMMUNE-MEDIATED MYOSITIS |
1 |
0.0004 |
| 18 |
TUMOUR HAEMORRHAGE |
1 |
0.0004 |
| 19 |
GRANULOMA |
1 |
0.0003 |
| 20 |
MYASTHENIA GRAVIS |
2 |
0.0002 |
| 21 |
NAIL DISORDER |
2 |
0.0002 |
| 22 |
BREATH SOUNDS ABNORMAL |
1 |
0.0002 |
| 23 |
EYELID PTOSIS |
2 |
0.0002 |
| 24 |
LOW DENSITY LIPOPROTEIN INCREASED |
1 |
0.0001 |
| 25 |
BASAL CELL CARCINOMA |
2 |
0.0001 |
| 26 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 27 |
AFFECTIVE DISORDER |
1 |
0.0001 |
| 28 |
RHINITIS |
1 |
0.0001 |
| 29 |
CARDIAC MURMUR |
1 |
0.0001 |
| 30 |
BLOOD TRIGLYCERIDES INCREASED |
2 |
0.0001 |
| 31 |
RECALLED PRODUCT ADMINISTERED |
1 |
0.0001 |
| 32 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
1 |
0.0001 |
| 33 |
BODY HEIGHT DECREASED |
1 |
0.0001 |
| 34 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 35 |
NEPHROPATHY TOXIC |
1 |
0.0001 |
| 36 |
SPINAL PAIN |
1 |
0.0001 |
| 37 |
PHARYNGITIS |
1 |
0.0001 |
| 38 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 39 |
MALIGNANT MELANOMA |
1 |
0.0001 |
| 40 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 41 |
ANKLE FRACTURE |
1 |
0.0001 |
| 42 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 43 |
SKIN FISSURES |
1 |
0.0001 |
| 44 |
KIDNEY INFECTION |
1 |
0.0001 |
| 45 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 46 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 47 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 48 |
DEAFNESS |
1 |
0.0000 |
| 49 |
GASTRITIS |
1 |
0.0000 |
| 50 |
DYSPHONIA |
2 |
0.0000 |
| 51 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 52 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 53 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 54 |
BRONCHITIS |
2 |
0.0000 |
| 55 |
THROMBOSIS |
2 |
0.0000 |
| 56 |
BLINDNESS |
1 |
0.0000 |
| 57 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 58 |
OSTEOPOROSIS |
1 |
0.0000 |
| 59 |
COMPLETED SUICIDE |
2 |
0.0000 |
| 60 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 61 |
HYPOKALAEMIA |
1 |
0.0000 |
| 62 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 63 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 64 |
DRY EYE |
1 |
0.0000 |
| 65 |
ILLNESS |
2 |
0.0000 |
| 66 |
OEDEMA |
1 |
0.0000 |
| 67 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 68 |
INFLUENZA |
2 |
0.0000 |
| 69 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 70 |
HERPES ZOSTER |
1 |
0.0000 |
| 71 |
NASAL CONGESTION |
1 |
0.0000 |
| 72 |
WHEEZING |
1 |
0.0000 |
| 73 |
CATARACT |
1 |
0.0000 |
| 74 |
VERTIGO |
1 |
0.0000 |
| 75 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 76 |
RENAL FAILURE |
2 |
0.0000 |
| 77 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 78 |
BURNING SENSATION |
1 |
0.0000 |
| 79 |
EPISTAXIS |
1 |
0.0000 |
| 80 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 81 |
DRUG INTERACTION |
2 |
0.0000 |
| 82 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 83 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 84 |
BALANCE DISORDER |
1 |
0.0000 |
| 85 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 86 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 87 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 88 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 89 |
SYNCOPE |
1 |
0.0000 |
| 90 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 91 |
SINUSITIS |
1 |
0.0000 |
| 92 |
HYPERTENSION |
2 |
0.0000 |
| 93 |
ASTHMA |
1 |
0.0000 |
| 94 |
DEPRESSION |
2 |
0.0000 |
| 95 |
JOINT SWELLING |
1 |
0.0000 |
| 96 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 97 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 98 |
DRY SKIN |
1 |
0.0000 |
| 99 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 100 |
INFECTION |
1 |
0.0000 |
| 101 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 102 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 103 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 104 |
PNEUMONIA |
2 |
0.0000 |
| 105 |
FALL |
2 |
0.0000 |
| 106 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 107 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 108 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 109 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 110 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 111 |
ALOPECIA |
1 |
0.0000 |
| 112 |
HYPOTENSION |
1 |
0.0000 |
| 113 |
SOMNOLENCE |
1 |
0.0000 |
| 114 |
RASH |
2 |
0.0000 |
| 115 |
WEIGHT INCREASED |
1 |
0.0000 |
| 116 |
FEELING ABNORMAL |
1 |
0.0000 |
| 117 |
COUGH |
1 |
0.0000 |
| 118 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 119 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 120 |
HEADACHE |
2 |
0.0000 |
| 121 |
PRURITUS |
1 |
0.0000 |
| 122 |
DEATH |
2 |
0.0000 |
| 123 |
MALAISE |
1 |
0.0000 |
| 124 |
DYSPNOEA |
1 |
0.0000 |
| 125 |
PAIN |
1 |
0.0000 |
| 126 |
DRUG INEFFECTIVE |
2 |
0.0000 |
| 127 |
FATIGUE |
1 |
0.0000 |